Silk Road Medical Inc (NAS:SILK)
$ 21.3 -0.08 (-0.37%) Market Cap: 840.15 Mil Enterprise Value: 745.45 Mil PE Ratio: 0 PB Ratio: 5.69 GF Score: 78/100

Silk Road Medical Inc TCAR in Practice: Investor Education Webcast Transcript

May 25, 2023 / 03:00PM GMT
Release Date Price: $29.92 (-7.48%)
Erica J. Rogers
Silk Road Medical, Inc - President, CEO & Director

Good morning, everyone, and thank you for joining us for a panel discussion between our Executive Medical Director, Dr. Sumaira Macdonald and 2 well-respected vascular surgeons, Dr. Michael Stoner and Dr. Sonya Noor, who are leading practitioners in the treatment of carotid artery disease.

I'll turn the line to Dr. Macdonald to introduce our KOLs shortly. But first, I want to acknowledge that we are fortunate to have her here at Silk Road. Many of you have had the chance to hear from Dr. Macdonald in the past, but for those who have not, she was a vascular radiologist and honorary clinical senior lecturer at Newcastle University and the Freeman Hospital in the United Kingdom before joining Silk Road. She is well regarded for her career long efforts to improve endovascular interventions dating all the way back to her PhD where she focused on neuroprotection and flow dynamics during carotid artery stenting. She was an early adopter of the transcarotid approach, offering TCAR to patients as early as 2011. In addition to being

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot